Gilead’s COVID-19 antiviral Veklury blew past sales estimates in late 2021 as omicron surged, vaccinations lagged

Gilead's COVID-19 antiviral Veklury blew past sales estimates in late 2021 as omicron surged, vaccinations lagged kdunleavy Wed, 02/02/2022 - 07:39

Click to view original post